Document is current
Any future updates will be listed below
-
Authors
Park, John J.
Stewart, Ashleigh
Irvine, Mal
Pedersen, Bernadette
Ming, Zizhen
Carlino, Matteo S.
Diefenbach, Russell J. http://orcid.org/0000-0002-8433-4336
Rizos, Helen http://orcid.org/0000-0002-2094-9198
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1128951, 1093017, 1130423)
- License Information
-
More Information
Article History
Received: 17 November 2021
Revised: 20 February 2022
Accepted: 4 March 2022
First Online: 29 March 2022
Competing interests
: MSC has served on advisory boards for Bristol-Myers Squibb, MSD, Amgen, Novartis, Pierre Fabre, Roche, Sanofi, Merck, Ideaya, Regeneron, Nektar, Eisai, Q biotics, Oncosec, and honoraria from Bristol-Myers Squibb, MSD, Novartis. These companies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. All remaining authors have declared no conflicts of interest.
